title: Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure.
abstract: The effects of dietary fat saturation on eicosanoid urinary excretion, platelet aggregation (PA) and blood pressure (BP) were studied in 42 healthy subjects. They consumed four consecutive diets differing in their fat saturation [saturated (SFA); monounsaturated (MUFA); polyunsaturated n-6 (PUFA n-6); and polyunsaturated n-6/n-3, (PUFA n-3)]. Each diet period lasted 5 weeks. There were no differences in 24-h 2,3-dinor-6- keto-prostaglandin F1 alpha excretion among dietary periods. A significant effect was noted regarding the excretion of 11-dehydro-thromboxane B2 (P < 0.0001). During the PUFA n-6 phase the excretion was significantly higher than during SFA and MUFA periods. Dietary fatty acid composition had a significant effect on ADP (1 mumolL-1) and collagen (2 mgL-1) induced PA. Dietary fat also had a significant effect on systolic and diastolic blood pressure (P < 0.0001). Both were significantly higher during the SFA period than during the other three periods. Our findings suggest that changes in dietary fatty acids may have mild, but significant, effects on eicosanoid production, platelet aggregation and blood pressure.
authors.affiliation: Unidad de Lípidos, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Lahoz
authors.forename: R
authors.initials: R
authors.lastname: Alonso
authors.forename: J M
authors.initials: JM
authors.lastname: Ordovás
authors.forename: A
authors.initials: A
authors.lastname: López-Farré
authors.forename: M
authors.initials: M
authors.lastname: de Oya
authors.forename: P
authors.initials: P
authors.lastname: Mata
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives / Q000652:urine; D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D004041:Dietary Fats / Q000008:administration & dosage*; D015777:Eicosanoids / Q000652:urine*; D019332:Endothelin-1 / Q000097:blood; D004734:Energy Metabolism; D005227:Fatty Acids / Q000008:administration & dosage*; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D010974:Platelet Aggregation; D013929:Thromboxane B2 / Q000031:analogs & derivatives / Q000652:urine
chemical_list: D004041:Dietary Fats; D015777:Eicosanoids; D019332:Endothelin-1; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D010743:Phospholipids; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C028290:2,3-dinor-6-ketoprostaglandin F1alpha; C049235:11-dehydro-thromboxane B2; D002784:Cholesterol